Hematology
Quality Assurance
HEM-QAQuality assurance is the work that lets a haematology result be defended after it leaves the bench: external surveys that compare the laboratory against its peers, control and calibration data read against a defined rule set, stain quality checked before any morphology is called, and procedures that are current and authorised. It is a small share of the exam but it touches every other domain, because a beautifully performed count reported off an out-of-control run is still a wrong result. Expect scenarios that ask what to do next rather than what a term means. Quality Assurance is one of the eight competency areas assessed in the Hematology Fields-of-Practice examination set by CAMLPR.
Running external survey specimens
External survey providers post unknown samples to the laboratory several times a year, and the graded return is one of the few objective checks that counts leaving the bench agree with peer laboratories using the same method. The technologist treats each survey vial exactly as a patient specimen: routine analyser, routine operator, routine review, no extra repeats that patient work would not get, and no phone call to a neighbouring site before submission. Unacceptable grades trigger a documented investigation covering method, reagents, operator and paperwork, followed by corrective action and a check that the fix held.
A regional laboratory receives its second external survey shipment of the year for the automated cell counter. The evening supervisor asks how the five vials should be handled so the challenge remains valid. Which approach is correct?
A haematology laboratory is graded unacceptable for the platelet count on two successive external surveys, although its own patient platelet results and control data look stable. What is the appropriate first move?
Keeping bedside haematology devices trustworthy
Point-of-care testing moves haematology away from the laboratory — handheld haemoglobin meters on dialysis and surgical units, INR devices in anticoagulation clinics, bedside platelet testing in theatre — but the laboratory usually keeps oversight of them. That means signing off operator training and recertification, confirming each device runs its liquid or electronic controls on schedule, tracking lot-to-lot performance, and comparing split specimens against the main analyser at defined intervals. A consistent gap between meter and core method is a calibration problem rather than a rounding quirk, and the device stays out of service until it is resolved and documented.
On a renal dialysis unit, a handheld haemoglobin meter reads roughly 12 g/L above the core laboratory analyser across six split specimens drawn the same morning. What should the laboratory do?
An anticoagulation clinic's point-of-care meter is validated to report INR values up to 4.5. A fingerstick sample from a warfarin patient returns a result flagged as above that upper limit. What is the appropriate next step?
Reading control and calibration data
Control material is only useful if somebody reads it properly. Each shift the technologist compares control results against the assigned mean and standard deviation, applies the laboratory's rule set — 1-3s, 2-2s, R-4s, 4-1s, 10-x — and decides whether the run can be released. Calibration data is judged the same way: after a lamp change, major service or a new reagent lot, calibration is verified and every control level is repeated before patient testing resumes. Monthly summaries of mean, standard deviation and coefficient of variation show whether precision is holding over time or quietly drifting.
The chart plots six consecutive runs of the two haemoglobin control levels. Levels 1 and 2 track close to their means until run 6, where level 1 sits at +2.4 SD and level 2 at -2.1 SD in the same run. Which control rule has been broken?
A service engineer replaces the optical bench lamp on the haematology analyser during a scheduled visit. Before patient samples are processed again, what does the laboratory need to do?
Telling scatter apart from bias
Two kinds of error appear on a control chart and they call for different responses. Random error is scatter — one wild point from an air bubble, a partly clotted control, an unstable pipette — and it widens the standard deviation without moving the mean. Systematic error moves the mean itself: an abrupt shift the day a reagent or calibrator lot changes, or a slow trend as a lamp ages, a control deteriorates or a temperature creeps. Reading the pattern across several runs, instead of reacting to a single flagged point, is what tells the technologist which one is in front of them.
The chart plots twelve days of the normal-level MCV control. Days 1 to 6 scatter evenly about the mean; from day 7 onward every point sits between +1.5 and +2.5 SD. A new reagent lot came into use on day 7. How is this pattern best described?
A haemoglobin control that has tracked close to its mean for six weeks returns one point 3.4 SD low. The immediate repeat falls within 1 SD, the four runs that follow are unremarkable, and no maintenance was carried out between them. Which explanation fits best?
Judging the stain before judging the film
Morphology cannot be reported off a badly stained film. Before calling a differential the technologist checks that the Romanowsky stain has produced the expected colour balance: orange-red erythrocyte cytoplasm, purple nuclear chromatin with visible parachromatin, and clearly tinted neutrophil and eosinophil granules. Films that are too blue point to buffer that is too alkaline; washed-out pink films point to acidic buffer or over-rinsing. Granular deposit lying above the cells means unfiltered or oxidised stain. Each fault has a documented remedy — adjust buffer pH, filter or replace the stain, change the timings — and affected films are restained rather than reported.
Films from this morning's automated stainer batch all look excessively blue: erythrocytes appear grey-green, nuclear chromatin is inky and dense, and neutrophil granules are hard to resolve. Which adjustment should be made?
A fine dark granular deposit lies over every film in a rack, sitting in a plane above the cells rather than within them, and it obscures the platelet estimate. What is the most likely cause?
Working from controlled, current procedures
Every procedure used at the bench should be the version the laboratory has authorised, and it should be possible to prove that. Controlled documents carry a title, a version number, an effective date, an approval signature and a stated review interval. When a method changes, the revised version is approved and released, staff are trained and sign that they have read it, and the copy it replaces is withdrawn from the working area and archived for the retention period. Uncontrolled photocopies taped inside cupboards and personal notebooks are the usual failure, because they outlive the revision they were taken from.
A technologist keeps a photocopy of the reticulocyte count procedure taped inside a cupboard door for quick reference at the bench. The electronic master was revised eight weeks ago. What does document control require here?
After a method change, a haematology laboratory approves and releases a new version of its manual platelet estimate procedure. What should happen to the version it replaces?
Back to all hematology areas in the Hematology study guide.
MLTPrep is an independent study resource. Not affiliated with or endorsed by CAMLPR. Always confirm current requirements with CAMLPR directly.